Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,670,000 | 1,611,000 | 901,279 | 1,052,000 | 839,000 |
| Marketable Securities | 159,000 | 164,000 | 1,475,394 | 1,417,000 | 137,000 |
| Inventories | 2,251,000 | 2,222,000 | 2,160,669 | 2,080,000 | 2,165,000 |
| Other current assets | 8,927,000 | 8,151,000 | 6,403,691 | 6,022,000 | 7,102,000 |
| TOTAL | $13,007,000 | $12,148,000 | $10,941,034 | $10,749,000 | $10,243,000 |
| Non-Current Assets | |||||
| PPE Net | 6,526,000 | 6,594,000 | 6,680,959 | 6,649,000 | 6,603,000 |
| Intangibles | 1,861,000 | 1,839,000 | 1,859,401 | 1,808,000 | 1,775,000 |
| Other Non-Current Assets | 310,000 | 3,109,000 | 3,121,318 | 3,121,000 | 3,128,000 |
| TOTAL | $8,697,000 | $11,542,000 | $11,661,678 | $11,578,000 | $11,506,000 |
| Total Assets | $21,704,000 | $23,690,000 | $22,602,711 | $22,327,000 | $21,749,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,596,000 | 1,372,000 | 1,324,444 | 1,551,000 | 1,751,000 |
| Accounts payable and accrued liabilities | 6,795,000 | 6,669,000 | 7,136,967 | 715,000 | 7,207,000 |
| TOTAL | $8,391,000 | $8,041,000 | $8,461,411 | $8,808,000 | $8,958,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,705,000 | 3,835,000 | 2,947,631 | 3,092,000 | 2,686,000 |
| Other Non-Current Liabilities | 2,669,000 | 2,569,000 | 2,464,464 | 1,490,000 | 2,006,000 |
| TOTAL | $7,159,000 | $7,163,000 | $6,192,740 | $6,131,000 | $5,491,000 |
| Total Liabilities | $15,550,000 | $15,204,000 | $14,654,151 | $14,939,000 | $14,449,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,490,000 | 1,495,000 | 1,496,868 | 1,506,000 | 1,510,000 |
| Retained earnings | 4,469,000 | 4,074,000 | 3,533,746 | 2,946,000 | 2,874,000 |
| Other shareholders' equity | -839,000 | 1,917,000 | 1,906,770 | 1,905,000 | 1,901,000 |
| TOTAL | $5,369,000 | $7,727,000 | $7,167,915 | $6,581,000 | $6,501,000 |
| Total Liabilities And Equity | $20,919,000 | $22,931,000 | $21,822,066 | $21,520,000 | $20,950,000 |